Search

Search Constraints

You searched for: Subject 3 -- 1

Search Results

7. Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) treated with alpelisib (ALP). Issue 28 (1st October 2022)